Price $87.21 |
Market Cap
43.44B
|
Sector Health Care |
Div. Growth
17.90%
|
|
P/E
32.4
|
P/B
5.53
|
P/S
3.9
|
Dividend %
1.00%
|
|
P/CF
409.3
|
P/FCF
62.4
|
Op. Cash Flow
1.86M
|
FCF
1.3
|
|
Op. Margin
13.60%
|
Net Margin
14.30%
|
ROE
19.50%
|
ROI
12.00%
|
|
ROA
9.50%
|
EPS Growth
78.90%
|
Current Ratio
2.1
|
Debt/Equity
44.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $5.91 | - | - | 76.8M | Strong Buy |
| Apollo Endosurgery Inc (APEN) | $3.32 | - | - | 61.4M | Strong Buy |
| American Renal Associates Hold (ARA) | $6.64 | - | - | 240.3M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLN) | $0.70 | - | - | 12.8M | Strong Buy |
| MTBC Inc (MTBC) | $4.52 | - | - | 58.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
